Cell Biotech Co., Ltd. (KOSDAQ:049960)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,800
+600 (4.55%)
At close: Jan 30, 2026
-4.17%
Market Cap90.34B
Revenue (ttm)50.65B -3.7%
Net Income12.59B +14.7%
EPS1,839.56 +14.7%
Shares Out6.84M
PE Ratio7.18
Forward PEn/a
Dividend450.00 (3.40%)
Ex-Dividend DateDec 29, 2025
Volume56,741
Average Volume19,220
Open13,290
Previous Close13,200
Day's Range13,290 - 13,960
52-Week Range11,350 - 14,660
Beta0.28
RSI51.40
Earnings DateFeb 13, 2026

About Cell Biotech

Cell Biotech Co., Ltd., a biotechnology company, develops lactic acid bacteria products in South Korea and internationally. It engages in the probiotics, microbiome, and anticancer new drug businesses. The company sells its products through partnerships with multinational companies and local retailers under the DUOLAC, DUOLAB, LACTOClear, and LAB2PRO brand names. Cell Biotech Co., Ltd. was founded in 1995 and is based in Gimpo-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1995
Employees 101
Stock Exchange KOSDAQ
Ticker Symbol 049960
Full Company Profile

Financial Performance

In 2024, Cell Biotech's revenue was 49.91 billion, a decrease of -7.20% compared to the previous year's 53.79 billion. Earnings were 15.13 billion, an increase of 139.96%.

Financial Statements